Through our partnership with Invitae we are able to offer certain genetic testing related to cardiac illnesses for FREE. Absolutely no cost to you. There are some tests which may cost money, but it is not thousands of dollars. You can get testing done for a small fee if they are not already free or covered by your insurance. 

• Invitae Arrhythmia and Cardiomyopathy: Comprehensive Panel Genetic testing for up to 150 genes that cause hereditary primary arrhythmia and/or cardiomyopathy, as well as syndromic causes of cardiomyopathy.

• Invitae Arrhythmia Comprehensive Panel: Genetic testing for up to 75 genes that cause arrhythmia and arrhythmogenic cardiomyopathy, including long QT syndrome (LQTS), short QT syndrome (SQTS), Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (CPVT), and arrhythmogenic right ventricular cardiomyopathy (ARVC).
• Invitae Arrhythmogenic Cardiomyopathy Panel: Genetic testing for up to 24 genes that cause arrhythmogenic cardiomyopathy, including ARVC and arrhythmogenic forms of DCM and HCM.
• Invitae Brugada Syndrome Test: Genetic testing for up to 20 genes that cause Brugada syndrome, an arrhythmia that can cause fainting, seizure-like episodes, or cardiac arrest.
• Invitae Catecholaminergic Polymorphic Ventricular Tachycardia Panel: Genetic testing for 8 genes that cause catecholaminergic polymorphic ventricular tachycardia (CPVT), an arrhythmia that can cause fainting and/or cardiac arrest.
• Invitae Long QT Syndrome Panel: Genetic testing for up to 17 genes that cause longQT syndrome (LQTS), an arrhythmia that can cause fainting, seizure-like episodes, or cardiac arrest.
• Invitae Short QT Syndrome Panel: Genetic testing for up to 6 genes that cause short QT syndrome (SQTS), an arrhythmia that can cause fainting, seizure-like episodes, or cardiac arrest.

• Invitae Cardiomyopathy Comprehensive Panel: Genetic testing for up to 106 genes that cause inherited cardiomyopathy, including arrhythmogenic right ventricular cardiomyopathy (ARVC), dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), left ventricular noncompaction (LVNC), and some syndromic causes of cardiomyopathy.
• Invitae Arrhythmogenic Cardiomyopathy Panel: Genetic testing for up to 24 genes that cause arrhythmogenic cardiomyopathy, including ARVC and arrhythmogenic forms of DCM and HCM.
• Invitae Dilated Cardiomyopathy Panel: Genetic testing for up to 70 genes that cause dilated cardiomyopathy (DCM), a cardiomyopathy that can cause chest pain, heart failure, arrhythmia or stroke.
• Invitae Hereditary Hemochromatosis Panel: Genetic testing for 5 genes associated with hereditary hemochromatosis (HH), a genetic disorder that causes increased iron absorption and can lead to iron overload.
• Invitae Hypertrophic Cardiomyopathy Panel: Genetic testing for up to 60 genes that cause hypertrophic cardiomyopathy (HCM), a cardiomyopathy that can cause chest pain, heart failure, or cardiac arrest.
• Invitae Left Ventricular Noncompaction Panel: Genetic testing for up to 19 genes that cause left ventricular noncompaction (LVNC), a cardiomyopathy causing excessive trabeculations, arrhythmia, and/or heart failure.
• Invitae RASopathies Comprehensive Panel: Genetic testing for 18 genes that are associated with RASopathies (also known as Noonan spectrum disorders)—a class of pediatric disorders whose spectrum of symptoms include distinctive facial features, heart defects, developmental delay, and an increased risk of malignancies.
• Invitae Transthyretin Amyloidosis Test: Genetic testing for the gene TTR which causes transthyretin amyloidosis, a progressive neuropathy featuring cardiomyopathy, nephropathy, or vitreous opacities.

• Invitae Cardiomyopathy and Skeletal Muscle Disease Panel: Genetic testing for up to 159 genes that are known to be associated with either cardiomyopathy or skeletal myopathy

•  Invitae Aortopathy Comprehensive Panel: Genetic testing for up to 27 genes which cause aortopathy; presenting as isolated thoracic aortic aneurysms and/or dissections (TAAD) or as a syndrome.
• Invitae Ehlers-Danlos Syndrome Panel: Genetic testing for 15 genes which cause Ehlers-Danlos syndrome (EDS) or other conditions that may present with joint hypermobility, connective tissue or bone fragility, myopathy with joint laxity, and/or aortopathy.
• Invitae Loeys-Dietz Syndrome Panel: Genetic testing for 4 genes that cause Loeys-Dietz syndrome (LDS), a connective tissue disorder with vascular involvement, and 2 genes that clinically overlap with LDS.
• Invitae Marfan Syndrome Test: Genetic testing for the gene FBN1 which causes Marfan syndrome, a connective tissue disorder involving the cardiovascular, skeletal, pulmonary, and ocular systems.

• Invitae Familial Hypercholesterolemia Panel: Genetic testing for 4 genes that cause familial hypercholesterolemia (FH), a hereditary risk factor for premature coronary artery disease, and 2 genes with clinical overlap can be added.

• Invitae Pulmonary Arterial Hypertension Panel: Genetic testing for up to 9 genes which cause pulmonary arterial hypertension (PAH), hypertension featuring fatigue, palpitations, edema, and heart failure.
• Invitae Hereditary Hemorrhagic Telangiectasia Panel: Genetic testing for 5 genes that cause hereditary hemorrhagic telangiectasia (HHT), a vascular dysplasia resulting in abnormalities of arterial and venous vessels.
• Invitae Capillary Malformation-Arteriovenous Malformation Syndrome Test: Genetic testing for capillary malformation-arteriovenous malformation (CM-AVM), a vascular disorder characterized by capillary malformations, which generally present at birth, and may also include arteriovenous malformations, arteriovenous fistulas, or Parkes-Weber syndrome.

• Invitae Congenital Heart Disease Panel: This panel tests 42 genes associated with isolated and syndromic causes of congenital heart disease, including some genes associated with heterotaxy that have specifically been linked to congenital heart defects.
• Invitae CHARGE Syndrome Test: Genetic testing for CHD7, the gene associated with CHARGE syndrome. CHARGE syndrome is characterized by coloboma, heart defect, choanal atresia, retarded growth and development, genital abnormalities, and ear anomalies.
• Invitae Holt-Oram Syndrome Test: Genetic testing for TBX5, which is the primary gene associated with Holt-Oram syndrome (HOS), a disorder characterized by upper-limb abnormalities and heart defects.
• Invitae RASopathies Comprehensive Panel: Genetic testing for 18 genes that are associated with RASopathies (also known as Noonan spectrum disorders)—a class of pediatric disorders whose spectrum of symptoms include distinctive facial features, heart defects, developmental delay, and an increased risk of malignancies.
• Invitae Sotos Syndrome Test: Genetic testing for NSD1, the primary gene associated with Sotos syndrome; characterized by distinct facial features, excessive growth during childhood, macrocephaly, and mild-to-severe learning disability.